In addition, combining mp-MRI with patients’ PSA density information may further help identify patients who harbor significant and high-grade PCa as our study demonstrated PSAD was higher in patients with upgrading compared with those with non-upgrading [35]. The gene discussed is KLK3; the disease is posterior cortical atrophy.